Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study to evaluate the safety, tolerability, and immunogenicity of an HSV-2–targeted mRNA vaccine; enrollment is b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• HSV-2 mRNA vaccine

Snippet

Sponsor: Changchun BCHT Biotechnology Co. | Conditions: Genital Herpes | Phase 1 | Status: ENROLLING_BY_INVITATION